Publication: Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice
Loading...
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Wolters Kluwer Health
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Drozd, D. R., M. S. Saag, A. O. Westfall, W. C. Mathews, R. Haubrich, S. L. Boswell, S. R. Cole, et al. 2017. “Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.” Medicine 96 (14): e6275. doi:10.1097/MD.0000000000006275. http://dx.doi.org/10.1097/MD.0000000000006275.
Abstract
Abstract We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.
Description
Other Available Sources
Research Data
Keywords
Observational Study, ART, atripla, comparative effectiveness, HIV, single tablet regimen
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service